SCM

Silverarc Capital Management Portfolio holdings

AUM $691M
1-Year Est. Return 359.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+359.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$691M
AUM Growth
+$202M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
91
New
Increased
Reduced
Closed

Top Buys

1
+$33.1M
2
+$17.6M
3
+$14.8M
4
GUTS icon
Fractyl Health
GUTS
+$13.5M
5
BIIB icon
Biogen
BIIB
+$10.9M

Top Sells

1
+$39M
2
+$33.9M
3
+$20.5M
4
ETNB
89bio
ETNB
+$20M
5
SLNO icon
Soleno Therapeutics
SLNO
+$17.1M

Sector Composition

1 Healthcare 100%
2 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLMA icon
26
Olema Pharmaceuticals
OLMA
$1.94B
$9.14M 1.32%
+933,541
CLDX icon
27
Celldex Therapeutics
CLDX
$2B
$9.03M 1.31%
348,922
+150,481
SRRK icon
28
Scholar Rock
SRRK
$4.52B
$8.71M 1.26%
233,920
-107,090
VCYT icon
29
Veracyte
VCYT
$2.89B
$8.09M 1.17%
235,791
-212,704
SNDX icon
30
Syndax Pharmaceuticals
SNDX
$1.89B
$7.13M 1.03%
463,708
+60,744
RAPP
31
Rapport Therapeutics
RAPP
$1.38B
$6.06M 0.88%
+203,946
VRDN icon
32
Viridian Therapeutics
VRDN
$2.8B
$5.6M 0.81%
+259,509
ALKS icon
33
Alkermes
ALKS
$4.97B
$5.42M 0.78%
+180,513
TRVI icon
34
Trevi Therapeutics
TRVI
$1.53B
$5.39M 0.78%
588,789
+49,202
BBOT
35
BridgeBio Oncology
BBOT
$802M
$5.3M 0.77%
457,414
-155,979
ABEO icon
36
Abeona Therapeutics
ABEO
$277M
$5.25M 0.76%
994,754
+76,856
LXEO icon
37
Lexeo Therapeutics
LXEO
$524M
$5.17M 0.75%
+778,611
GLUE icon
38
Monte Rosa Therapeutics
GLUE
$1.35B
$5.15M 0.75%
+694,942
CGEN icon
39
Compugen
CGEN
$169M
$4.87M 0.7%
3,311,165
+277,286
PHVS icon
40
Pharvaris
PHVS
$1.84B
$4.59M 0.66%
+183,903
CELC icon
41
Celcuity
CELC
$5.17B
$4.38M 0.63%
+88,686
CERS icon
42
Cerus
CERS
$492M
$4.32M 0.63%
2,715,786
+227,495
CCCC icon
43
C4 Therapeutics
CCCC
$262M
$4.21M 0.61%
+1,897,383
TELA icon
44
TELA Bio
TELA
$38.7M
$4.15M 0.6%
2,782,923
+3,128
AARD
45
Aardvark Therapeutics
AARD
$272M
$4.08M 0.59%
306,912
+20,105
BCAX
46
Bicara Therapeutics
BCAX
$919M
$3.96M 0.57%
+250,606
BNTC icon
47
Benitec Biopharma
BNTC
$373M
$3.88M 0.56%
276,267
+23,033
KNSA icon
48
Kiniksa Pharmaceuticals
KNSA
$3.37B
$3.45M 0.5%
88,910
+12,951
CNTA
49
Centessa Pharmaceuticals
CNTA
$3.97B
$3.43M 0.5%
141,238
+136,238
EYPT icon
50
EyePoint Inc
EYPT
$1.45B
$3.29M 0.48%
+230,837
1
2
3 4